Many articles you’ve read recently or will read shortly will always have a rich part centered on the complexity of the medical landscape increasing including the number of treatment options available to patients continuing to expand and how this is changing the MSL function globally. I’ll not spend more time on that because it is evident enough, that, there is a growing demand … [Read more...]
Benchmarking the Cultural Emotional Index in Medical Affairs
I came to emotional intelligence because I suppose I felt I wasn’t as effective as I could be. I have a lot of knowledge that kind of built up over the years in a certain area and I wanted to become more effective in it. I was finding that I ended up doing a lot of administrative tasks and not really executing what I wanted to really deliver to patients and healthcare … [Read more...]
MSL Performance Metrics: Valuing the Role Through Product’s Lifecycle & Digitalization
MSL Performance Metrics have been a dilemma for the last decade or so. Many studies have been conducted to rethink the evaluation of the Medical Science Liaison function, I’ve personally conducted one on “The relation between the tracking/reporting system for MSLs in medical affairs departments in pharmaceutical companies located within the MENA region and its impact on the MSL … [Read more...]
The Winning Mindset for an Effective Medical and Commercial Collaboration in the Pharmaceutical Industry
With new challenges always come new opportunities. This has lately been the case within the rapidly changing world of medical affairs globally. This rapid change is multifactorial, yet it has been driven by the move to more specialized medicines and the rise of digital channels increasing the availability of data. This in return has created a growing need to overcome … [Read more...]
Augmenting MSL effectiveness in emerging markets of the Middle East
Through my experience as an MSL, it was integral to be an excellent communicator. I’ve worked primarily with insight gathering and therapeutic area support in the pre-approval stage of a drug, as well as on an established drug with medical affairs support where the role substantially changed compared to when working on a pipeline drug. The MSL role has evolved and is … [Read more...]